Daxor Corporation (DXR)
USD 8.2
(-0.97%)
USD 8.2
(-0.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 329.74 Thousand USD | -93.72% |
| 2022 | 5.25 Million USD | 10.58% |
| 2021 | 4.74 Million USD | 374.36% |
| 2020 | -1.72 Million USD | -249.14% |
| 2019 | -495.69 Thousand USD | 54.82% |
| 2018 | -1.21 Million USD | 3.96% |
| 2017 | -1.21 Million USD | -175.92% |
| 2016 | 1.23 Million USD | 119.49% |
| 2015 | -7.88 Million USD | -80.72% |
| 2014 | -4.5 Million USD | 63.72% |
| 2013 | - USD | -378.34% |
| 2012 | -2.68 Million USD | 79.26% |
| 2011 | - USD | -236.25% |
| 2010 | - USD | 14.48% |
| 2009 | - USD | -61.9% |
| 2008 | - USD | 63.85% |
| 2007 | - USD | 2068.59% |
| 2006 | - USD | 49.38% |
| 2005 | - USD | -140.91% |
| 2004 | - USD | 49.47% |
| 2003 | - USD | -758.37% |
| 2002 | - USD | -127.42% |
| 2001 | - USD | 1657.13% |
| 2000 | - USD | 203.92% |
| 1999 | - USD | 92.21% |
| 1998 | - USD | -200.0% |
| 1997 | - USD | -200.0% |
| 1996 | - USD | -93.33% |
| 1995 | - USD | -28.57% |
| 1994 | - USD | -12.5% |
| 1993 | - USD | -35.14% |
| 1992 | - USD | 294.74% |
| 1991 | -1.9 Million USD | 0.0% |
| 1990 | - USD | 100.0% |
| 1989 | -1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.58 Million USD | 0.0% |
| 2024 Q1 | 1643.00 USD | -100.0% |
| 2023 Q3 | 1.86 Million USD | 162.48% |
| 2023 Q1 | -1.33 Million USD | -118.98% |
| 2023 FY | - USD | -93.72% |
| 2023 Q4 | 3.06 Million USD | 63.92% |
| 2023 Q2 | -2.99 Million USD | -124.11% |
| 2022 Q4 | 7.03 Million USD | 84.79% |
| 2022 Q3 | 3.8 Million USD | 582.88% |
| 2022 Q1 | -788.48 Thousand USD | -123.38% |
| 2022 FY | - USD | 10.58% |
| 2022 Q2 | -788.48 Thousand USD | 0.0% |
| 2021 Q3 | 3.37 Million USD | 638.77% |
| 2021 Q2 | -626.04 Thousand USD | 0.0% |
| 2021 FY | - USD | 374.36% |
| 2021 Q4 | 3.37 Million USD | 0.0% |
| 2021 Q1 | -626.04 Thousand USD | -2376.43% |
| 2020 Q1 | -1.72 Million USD | -27759.56% |
| 2020 Q2 | -1.72 Million USD | 0.0% |
| 2020 FY | - USD | -249.14% |
| 2020 Q3 | 1.05 Million USD | 161.03% |
| 2020 Q4 | -25.28 Thousand USD | -102.4% |
| 2019 Q3 | -457.25 Thousand USD | -188.38% |
| 2019 FY | - USD | 54.82% |
| 2019 Q1 | 204.86 Thousand USD | 244.05% |
| 2019 Q2 | 517.36 Thousand USD | 152.54% |
| 2019 Q4 | -6182.00 USD | 98.65% |
| 2018 Q1 | -209.37 Thousand USD | 49.37% |
| 2018 Q3 | -142.21 Thousand USD | 32.07% |
| 2018 Q4 | -142.21 Thousand USD | 0.0% |
| 2018 FY | - USD | 3.96% |
| 2018 Q2 | -209.37 Thousand USD | 0.0% |
| 2017 Q3 | -413.56 Thousand USD | -1.49% |
| 2017 Q4 | -413.56 Thousand USD | 0.0% |
| 2017 FY | - USD | -175.92% |
| 2017 Q1 | -407.48 Thousand USD | -160.34% |
| 2017 Q2 | -407.48 Thousand USD | 0.0% |
| 2016 Q2 | 793.56 Thousand USD | 0.0% |
| 2016 FY | - USD | 119.49% |
| 2016 Q4 | -156.51 Thousand USD | 0.0% |
| 2016 Q3 | -156.51 Thousand USD | -119.72% |
| 2016 Q1 | 793.56 Thousand USD | 140.29% |
| 2015 FY | - USD | -80.72% |
| 2015 Q3 | -1.96 Million USD | 14.56% |
| 2015 Q4 | -1.96 Million USD | 0.0% |
| 2015 Q2 | -2.3 Million USD | 0.0% |
| 2015 Q1 | -2.3 Million USD | -6459.43% |
| 2014 Q2 | 633.24 Thousand USD | 0.0% |
| 2014 FY | - USD | 63.72% |
| 2014 Q1 | 633.24 Thousand USD | 139.0% |
| 2014 Q4 | 36.25 Thousand USD | 0.0% |
| 2014 Q3 | 36.25 Thousand USD | -94.28% |
| 2013 Q4 | -1.62 Million USD | 0.0% |
| 2013 Q1 | -1.44 Million USD | -341.98% |
| 2013 FY | - USD | -378.34% |
| 2013 Q3 | -1.62 Million USD | -12.37% |
| 2013 Q2 | -1.44 Million USD | 0.0% |
| 2012 FY | - USD | 79.26% |
| 2012 Q4 | 597.21 Thousand USD | 0.0% |
| 2012 Q3 | 597.21 Thousand USD | 0.0% |
| 2011 Q1 | -2.3 Million USD | -168.19% |
| 2011 Q3 | -6.95 Million USD | -2208.9% |
| 2011 Q4 | -2.47 Million USD | 64.43% |
| 2011 FY | - USD | -236.25% |
| 2011 Q2 | -301.28 Thousand USD | 86.93% |
| 2010 FY | - USD | 14.48% |
| 2010 Q4 | 3.37 Million USD | -24.52% |
| 2010 Q3 | 4.47 Million USD | 1903.64% |
| 2010 Q2 | 223.48 Thousand USD | -60.47% |
| 2010 Q1 | 565.39 Thousand USD | 182.47% |
| 2009 Q4 | -685.55 Thousand USD | -124.77% |
| 2009 FY | - USD | -61.9% |
| 2009 Q1 | -1.34 Million USD | -175.44% |
| 2009 Q2 | 6.69 Million USD | 597.65% |
| 2009 Q3 | 2.76 Million USD | -58.64% |
| 2008 Q1 | 7.38 Million USD | 119.93% |
| 2008 Q3 | 8.8 Million USD | 341.98% |
| 2008 Q4 | 1.78 Million USD | -79.75% |
| 2008 FY | - USD | 63.85% |
| 2008 Q2 | 1.99 Million USD | -73.04% |
| 2007 Q2 | 2.39 Million USD | -22.97% |
| 2007 FY | - USD | 2068.59% |
| 2007 Q3 | 2 Million USD | -16.29% |
| 2007 Q1 | 3.11 Million USD | 3226.02% |
| 2007 Q4 | 3.35 Million USD | 67.41% |
| 2006 Q1 | -4331.00 USD | 99.47% |
| 2006 Q4 | 93.58 Thousand USD | 110.61% |
| 2006 Q3 | -882.36 Thousand USD | -607.16% |
| 2006 Q2 | 173.98 Thousand USD | 4117.09% |
| 2006 FY | - USD | 49.38% |
| 2005 Q1 | -329.59 Thousand USD | -35.81% |
| 2005 Q2 | -1.07 Million USD | -227.07% |
| 2005 Q3 | 1 Million USD | 193.31% |
| 2005 Q4 | -810.79 Thousand USD | -180.6% |
| 2005 FY | - USD | -140.91% |
| 2004 Q2 | -249.46 Thousand USD | -591.96% |
| 2004 Q3 | -44.54 Thousand USD | 82.14% |
| 2004 Q4 | -242.69 Thousand USD | -444.85% |
| 2004 FY | - USD | 49.47% |
| 2004 Q1 | 50.7 Thousand USD | 114.09% |
| 2003 Q4 | - USD | -113.3% |
| 2003 FY | - USD | -758.37% |
| 2003 Q3 | - USD | 28.3% |
| 2003 Q1 | - USD | 38.12% |
| 2003 Q2 | - USD | 2.27% |
| 2002 Q1 | - USD | -36.41% |
| 2002 Q4 | - USD | -428.75% |
| 2002 Q2 | - USD | 46.38% |
| 2002 FY | - USD | -127.42% |
| 2002 Q3 | - USD | 29.61% |
| 2001 Q2 | - USD | 53.66% |
| 2001 Q1 | - USD | 154.41% |
| 2001 FY | - USD | 1657.13% |
| 2001 Q4 | - USD | -33.64% |
| 2001 Q3 | - USD | 34.97% |
| 2000 FY | - USD | 203.92% |
| 2000 Q2 | - USD | -143.24% |
| 2000 Q1 | - USD | 133.77% |
| 2000 Q3 | - USD | 296.23% |
| 2000 Q4 | - USD | -240.79% |
| 1999 Q1 | 300 Thousand USD | 250.0% |
| 1999 FY | - USD | 92.21% |
| 1999 Q4 | - USD | -208.25% |
| 1999 Q3 | 300 Thousand USD | 400.0% |
| 1999 Q2 | -100 Thousand USD | -133.33% |
| 1998 Q4 | -200 Thousand USD | -166.67% |
| 1998 Q2 | 100 Thousand USD | 150.0% |
| 1998 FY | - USD | -200.0% |
| 1998 Q3 | 300 Thousand USD | 200.0% |
| 1998 Q1 | -200 Thousand USD | 80.0% |
| 1997 Q2 | 200 Thousand USD | -33.33% |
| 1997 Q1 | 300 Thousand USD | 0.0% |
| 1997 FY | - USD | -200.0% |
| 1997 Q4 | -1 Million USD | -300.0% |
| 1997 Q3 | 500 Thousand USD | 150.0% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1996 Q2 | 300 Thousand USD | 400.0% |
| 1996 Q1 | -100 Thousand USD | -150.0% |
| 1996 FY | - USD | -93.33% |
| 1996 Q4 | - USD | -100.0% |
| 1995 FY | - USD | -28.57% |
| 1995 Q3 | 200 Thousand USD | -33.33% |
| 1995 Q2 | 300 Thousand USD | -57.14% |
| 1995 Q1 | 700 Thousand USD | 75.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| 1994 FY | - USD | -12.5% |
| 1994 Q4 | 400 Thousand USD | -20.0% |
| 1994 Q3 | 500 Thousand USD | 0.0% |
| 1994 Q2 | 500 Thousand USD | 0.0% |
| 1994 Q1 | 500 Thousand USD | -44.44% |
| 1993 Q2 | 800 Thousand USD | 366.67% |
| 1993 Q4 | 900 Thousand USD | -18.18% |
| 1993 Q1 | - USD | 57.14% |
| 1993 Q3 | 1.1 Million USD | 37.5% |
| 1993 FY | - USD | -35.14% |
| 1992 FY | - USD | 294.74% |
| 1992 Q4 | -700 Thousand USD | -158.33% |
| 1992 Q3 | 1.2 Million USD | -45.45% |
| 1992 Q2 | 2.2 Million USD | 120.0% |
| 1992 Q1 | 1 Million USD | 233.33% |
| 1991 Q3 | 700 Thousand USD | 250.0% |
| 1991 Q4 | 300 Thousand USD | -57.14% |
| 1991 Q1 | -3.3 Million USD | -430.0% |
| 1991 Q2 | 200 Thousand USD | 106.06% |
| 1991 FY | - USD | -157.58% |
| 1990 FY | - USD | 430.0% |
| 1990 Q3 | 600 Thousand USD | -14.29% |
| 1990 Q2 | 700 Thousand USD | -30.0% |
| 1990 Q1 | 1 Million USD | 42.86% |
| 1990 Q4 | 1 Million USD | 66.67% |
| 1989 FY | - USD | -127.03% |
| 1989 Q2 | 600 Thousand USD | 0.0% |
| 1989 Q1 | 600 Thousand USD | -45.45% |
| 1989 Q3 | 400 Thousand USD | -33.33% |
| 1989 Q4 | 700 Thousand USD | 75.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 100.723% |
| AngioDynamics, Inc. | -14.29 Million USD | 102.307% |
| AtriCure, Inc. | -8.1 Million USD | 104.066% |
| Avinger, Inc. | -16.34 Million USD | 102.017% |
| Azenta, Inc. | 55.15 Million USD | 99.402% |
| BioLife Solutions, Inc. | -45.23 Million USD | 100.729% |
| The Cooper Companies, Inc. | 882.8 Million USD | 99.963% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 102.498% |
| Femasys Inc. | -13.16 Million USD | 102.504% |
| GlucoTrack, Inc. | -7.09 Million USD | 104.65% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 96.526% |
| Hologic, Inc. | 1.29 Billion USD | 99.975% |
| ICU Medical, Inc. | 307.69 Million USD | 99.893% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 99.986% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 103.508% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 99.327% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 105.015% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 105.015% |
| Masimo Corporation | 236.7 Million USD | 99.861% |
| Microbot Medical Inc. | -10.63 Million USD | 103.101% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 97.909% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 99.858% |
| Nephros, Inc. | -1.37 Million USD | 123.912% |
| NovoCure Limited | -175.86 Million USD | 100.187% |
| NEXGEL, Inc. | -2.73 Million USD | 112.078% |
| NEXGEL, Inc. | -2.73 Million USD | 112.078% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 100.381% |
| OraSure Technologies, Inc. | 76.15 Million USD | 99.567% |
| Pro-Dex, Inc. | 8.33 Million USD | 96.043% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 100.778% |
| Predictive Oncology Inc. | -13.18 Million USD | 102.501% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 113.127% |
| QuidelOrtho Corporation | 545.6 Million USD | 99.94% |
| Repligen Corporation | 124.29 Million USD | 99.735% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 214.059% |
| STAAR Surgical Company | 33.22 Million USD | 99.007% |
| Sharps Technology, Inc. | -8.98 Million USD | 103.672% |
| Utah Medical Products, Inc. | 24.8 Million USD | 98.671% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 99.858% |
| Jin Medical International Ltd. | 3.44 Million USD | 90.423% |